Effectiveness of mass oral cholera vaccination in Beira, Mozambique

Lucas, ME; Deen, JL; von Seidlein, L; Wang, XY; Ampuero, J; Puri, M; Ali, M; Ansaruzzaman, M; Amos, J; Macuamule, A; Cavailler, P; Guerin, PJ; Mahoudeau, C; Kahozi-Sangwa, P; Chaignat, CL; Barreto, A; Songane, FF; Clemens, JD; (2005) Effectiveness of mass oral cholera vaccination in Beira, Mozambique. The New England journal of medicine, 352 (8). pp. 757-67. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMoa043323

Text - Published Version
License: Copyright the publishers

Download (120kB) | Preview


: New-generation, orally administered cholera vaccines offer the promise of improved control of cholera in sub-Saharan Africa. However, the high prevalence of human immunodeficiency virus (HIV) infection in many cholera-affected African populations has raised doubts about the level of protection possible with vaccination. We evaluated a mass immunization program with recombinant cholera-toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in Beira, Mozambique, a city where the seroprevalence of HIV is 20 to 30 percent.<br/> : From December 2003 to January 2004, we undertook mass immunization of nonpregnant persons at least two years of age, using a two-dose regimen of rBS-WC vaccine in Esturro, Beira (population 21,818). We then assessed vaccine protection in a case-control study during an outbreak of El Tor Ogawa cholera in Beira between January and May 2004. To estimate the level of vaccine protection, antecedent rates of vaccination were compared between persons with culture-confirmed cholera severe enough to have prompted them to seek treatment and age- and sex-matched neighborhood controls without treated diarrhea.<br/> : We assessed the effectiveness of the vaccine in 43 persons with cholera and 172 controls. Receipt of one or more doses of rBS-WC vaccine was associated with 78 percent protection (95 percent confidence interval, 39 to 92 percent; P=0.004). The vaccine was equally effective in children younger than five years of age and in older persons. A concurrently conducted case-control study designed to detect bias compared persons with treated, noncholeraic diarrhea and controls without diarrhea in the same population and found no protection associated with receipt of the rBS-WC vaccine.<br/> : The rBS-WC vaccine was highly effective against clinically significant cholera in an urban sub-Saharan African population with a high prevalence of HIV infection.<br/>

Item Type: Article
Keywords: Adolescent, Adult, Case-Control Studies, Child, Child, Preschool, Cholera/epidemiology/*prevention & control, Cholera Toxin, *Cholera Vaccines, Diarrhea/epidemiology/virology, Feasibility Studies, Female, HIV Infections/complications, Humans, *Immunization Programs, Logistic Models, Male, Middle Aged, Mozambique/epidemiology, Peptide Fragments, Population Surveillance, Treatment Outcome, Vaccines, Inactivated, Vibrio cholerae/isolation & purification, Adolescent, Adult, Case-Control Studies, Child, Child, Preschool, Cholera, epidemiology, prevention & control, Cholera Toxin, Cholera Vaccines, Diarrhea, epidemiology, virology, Feasibility Studies, Female, HIV Infections, complications, Humans, Immunization Programs, Logistic Models, Male, Middle Aged, Mozambique, epidemiology, Peptide Fragments, Population Surveillance, Treatment Outcome, Vaccines, Inactivated, Vibrio cholerae, isolation & purification
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Research Centre: Vaccine Centre
PubMed ID: 15728808
Web of Science ID: 227147500005
URI: http://researchonline.lshtm.ac.uk/id/eprint/10257


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item